ABC | Volume 114, Nº5, Maio 2020

Ponto de Vista Costa et al. Implicação Cardiovascular do Covid-19 Arq Bras Cardiol. 2020; 114(5):834-838 15. Odegaard JI, Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med. 2012;2(3):a007724. 16. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics.. Lancet Infect Dis. 2009;9(12):737-46. 17. BBC News. Coronavirus disease named Covid-19. [citado 23 mar. 2020]. Disponível em: https://www.bbc.co.uk/news/world-asia-china-51466362. 18. Jiang S, Xia S, Ying T, Lu L. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell Mol Immunol. 2020 Feb 5. [Epub ahead of print]. 19. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Feb 7. [Epub ahead of print]. 20. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369(5):407-16. 21. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997; 95(1):163-8. 22. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.. 2020;395(10223):497-506. 23. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. 24. Dominguez AN, Martín AV. COVID-19. Punto de vista del cardiólogo. Rev Cubana Cardiol. 2020;26(1):1-5. 25. Brasil.Ministério da Saúde. Sobre a doença. Rio de Janeiro, DF:; 2020. [citado 22 mar. 2020]. Disponível em: https://coronavirus.saude.gov.br/ sobre-a-doenca#transmissao>. 26. American College of Cardiology. ACC Clinical Bulletin COVID-19 Clinical Guidance For the Cardiovascular Care Team; 2020. 27. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 Mar 18;pii:ehaa231. [Epub ahead of print]. 28. Poder Judiciário. Tribunal Regional do Trabalho 11ª Região, Ato 15/2020/ SGP. Estabelece medidas temporárias de prevenção ao contagio pelo novo coronavirus (COVI-19) Internet. [Citado em 20 Mar 2020] Disponível em: portal.trt11.jus.br 29. GlasserJW,HupertN,McCauleyMM,HatchettR.Modelingandpublichealth emergency responses: lessons from SARS. Epidemics. 2011;3(1):32-7. 30. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 Feb 19. [Epub ahead of print]. 31. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. 32. Kuiken T, Fouchier RAM, SchuttenM, Rimmelzwaan GF, van Amerongen G, vanRielD,etal.Newlydiscoveredcoronavirusastheprimarycauseofsevere acute respiratory syndrome. Lancet. 2003;362(9380):263–70. 33. Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: frommechanisms to potential therapeutic tools. Virol. Sin. 2020 Mar 3. [Epub ahead of print]. 34. Guimarães HP, Damasceno MC, Braga MA, Schubert DUC, Santana JCB, Freitas APR, et al. Coronavírus e medicina de emergência: recomendações paraoatendimento inicialdomédicoemergencistapelaAssociaçãoBrasileira deMedicinadeEmergência (ABRAMEDE). [citado23mar.2020].Disponível em :https://www.amib.org.br/fileadmin/user_upload/POSICIONAMENTO_ ABRAMEDE_-_CORONAVIRUS_-_03-__10032020.pdf. 35. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020Mar 11. [Epub ahead of print]. 36. Chinese Center for Disease Control and Prevention. The epidemiological characteristicsofanoutbreakof2019novelcoronavirusdiseases(COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020:41(2):145-51. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 838